CEO Joaquin Duato said the company is positioned for sustained growth in coming years even as competition batters Stelara, ...
Johnson & Johnson , fresh off a $14.6 billion deal to buy neurological drugmaker Intra-Cellular , reported fourth-quarter ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback